82 related articles for article (PubMed ID: 34254829)
1. Ascorbic acid: chemistry, biology and the treatment of cancer.
Du J; Cullen JJ; Buettner GR
Biochim Biophys Acta; 2012 Dec; 1826(2):443-57. PubMed ID: 22728050
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C: From nutrition to oxygen sensing and epigenetics.
Kietzmann T
Redox Biol; 2023 Jul; 63():102753. PubMed ID: 37263060
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Böttger F; Vallés-Martí A; Cahn L; Jimenez CR
J Exp Clin Cancer Res; 2021 Oct; 40(1):343. PubMed ID: 34717701
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases.
Hoppe C; Freuding M; Büntzel J; Münstedt K; Hübner J
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3025-3042. PubMed ID: 34402972
[TBL] [Abstract][Full Text] [Related]
5. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
Creagan ET; Moertel CG; O'Fallon JR; Schutt AJ; O'Connell MJ; Rubin J; Frytak S
N Engl J Med; 1979 Sep; 301(13):687-90. PubMed ID: 384241
[TBL] [Abstract][Full Text] [Related]
6. Genetically predicted vitamin C levels significantly affect patient survival and immunotypes in multiple cancer types.
Yuan J; Zhang YH; Hua X; Hong HQ; Shi W; Liu KX; Liu ZX; Huang P
Front Immunol; 2023; 14():1177580. PubMed ID: 37283769
[TBL] [Abstract][Full Text] [Related]
7. The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer.
Mussa A; Afolabi HA; Syed NH; Talib M; Murtadha AH; Hajissa K; Mokhtar NF; Mohamud R; Hassan R
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189677
[TBL] [Abstract][Full Text] [Related]
8. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.
Kontoghiorghes GJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430469
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate Is a Primary Antioxidant in Mammals.
Fujii J; Osaki T; Bo T
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234722
[TBL] [Abstract][Full Text] [Related]
10. High-Dose Vitamin C for Cancer Therapy.
Mussa A; Mohd Idris RA; Ahmed N; Ahmad S; Murtadha AH; Tengku Din TADAA; Yean CY; Wan Abdul Rahman WF; Mat Lazim N; Uskoković V; Hajissa K; Mokhtar NF; Mohamud R; Hassan R
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745630
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.
Timoshnikov VA; Selyutina OY; Polyakov NE; Didichenko V; Kontoghiorghes GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163169
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C (Ascorbate) and Redox Topics in Cancer.
Glorieux C; Buc Calderon P
Antioxid Redox Signal; 2021 Nov; 35(14):1157-1175. PubMed ID: 34254829
[No Abstract] [Full Text] [Related]
13. Influence of vitamin C and vitamin E on redox signaling: Implications for exercise adaptations.
Cobley JN; McHardy H; Morton JP; Nikolaidis MG; Close GL
Free Radic Biol Med; 2015 Jul; 84():65-76. PubMed ID: 25841784
[TBL] [Abstract][Full Text] [Related]
14. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C in Plants: Novel Concepts, New Perspectives, and Outstanding Issues.
Foyer CH; Kyndt T; Hancock RD
Antioxid Redox Signal; 2020 Mar; 32(7):463-485. PubMed ID: 31701753
[No Abstract] [Full Text] [Related]
16. Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate.
Jankowski CSR; Rabinowitz JD
Cancer Res; 2022 Oct; 82(19):3486-3498. PubMed ID: 35916672
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.
Venturelli S; Sinnberg TW; Niessner H; Busch C
Wien Med Wochenschr; 2015 Jun; 165(11-12):251-7. PubMed ID: 26065536
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
